Clinical Trial Update: Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on fecal microbiota transplantation for severe Clostridium difficile infection (pseudomembranous colitis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection
• Pseudomembranous Colitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Clostridium Difficile, Pseudomembranous Colitis | Phase 2 | Status: COMPLETED